Three of these cell lines were derived from patients with familial PD (fPD) harboring risk alleles for LRRK2, PRKN, or MAPT; the remaining lines were derived from patients with sporadic PD (sPD) (Table 3). This evidence concerns the gene MAPT and Platelet storage pool disease.